A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Privia Health Group, Inc. (“Privia Health”, “we”, “our”, or the “Company”) is a technology-driven, national physician-enablement company that collaborates with physician practices, health plans, and health systems to achieve the quadruple aim of better outcomes, lower costs, improved patient experience, and happier and more engaged providers. We seek to accomplish the quadruple aim by entering markets and organizing existing physicians and non-physician clinicians into a unique practice model that combines the advantages of a partnership in a large regional medical group (each, a “Medical Group”) with significant provider autonomy for the physicians (collectively, “Privia Physicians”) and non-physician clinicians (collectively “Privia Clinicians” and, together with the Privia Physicians, the “Privia Providers”) in our Medical Groups.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.1B | 2.1B | 1.7B | - | - | - |
| Net Income | 23M | 23M | 14M | 23M | -8.6M | -188M |
| EPS | $0.18 | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 |
| Free Cash Flow | 163M | 163M | 109M | 81M | 47M | 55M |
| ROIC | 7.9% | 3.4% | 1.6% | 9.0% | -1.9% | -62.0% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.11 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 34M | 34M | 17M | 21M | -19M | -217M |
| Operating Margin | 1.6% | 1.6% | 1.0% | - | - | - |
| ROE | 3.1% | 3.3% | 2.3% | 4.4% | -1.9% | -65.6% |
| Shares Outstanding | 127M | 127M | 131M | 121M | 107M | 103M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | -6.9M | N/A | N/A | N/A | N/A | 1.7B | 2.1B | 2.1B |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 42M | 44M | 256M | 130M | 110M | 126M | 138M | 138M |
| EBIT | 13M | 25M | -217M | -19M | 21M | 17M | 34M | 34M |
| Op. Margin | -194.7% | N/A | N/A | N/A | N/A | 1.0% | 1.6% | 1.6% |
| Net Income | 8.2M | 31M | -188M | -8.6M | 23M | 14M | 23M | 23M |
| Net Margin | -119.3% | N/A | N/A | N/A | N/A | 0.8% | 1.1% | 1.1% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | N/A | 27.2% | -62.0% | -1.9% | 9.0% | 1.6% | 3.4% | 7.9% |
| ROE | N/A | 24.6% | -65.6% | -1.9% | 4.4% | 2.3% | 3.3% | 3.1% |
| ROA | 1282.1% | 19.0% | -37.1% | -1.2% | 2.6% | 1.3% | 1.8% | 1.7% |
| Cash Flow | ||||||||
| Op. Cash Flow | 24M | 39M | 55M | 47M | 81M | 109M | 163M | 163M |
| Free Cash Flow | 19M | 39M | 55M | 47M | 81M | 109M | 163M | 163M |
| Owner Earnings | 23M | 37M | -201M | -25M | 37M | 45M | 82M | 82M |
| CapEx | 5.7M | 380K | 547K | 104K | 113K | 0 | 0 | 0 |
| Maint. CapEx | 1.4M | 1.8M | 2.5M | 4.6M | 6.5M | 7.3M | 9.9M | 9.9M |
| Growth CapEx | 4.3M | 0 | 0 | 0 | 0 | N/A | N/A | 0 |
| D&A | 1.4M | 1.8M | 2.5M | 4.6M | 6.5M | 7.3M | 9.9M | 9.9M |
| CapEx/OCF | N/A | N/A | 1.0% | 0.2% | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 207K | 484K | 254M | 67M | 37M | 57M | 71M | 71M |
| Debt Repayment | 618K | 0 | 287K | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | -17M | -51M | -275M | -336M | -381M | -977M | -950M | -470M |
| Cash & Equiv. | 47M | 85M | 321M | 348M | 390M | 491M | 480M | 480M |
| Long-Term Debt | 30M | 33M | 875K | 0 | 0 | N/A | N/A | 9.5M |
| Debt/Equity | N/A | 0.23 | 0.11 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Coverage | 3.4 | 13.4 | -197.7 | -38.2 | 2.5 | 59.6 | 136.4 | 136.4 |
| Equity | N/A | 147M | 427M | 499M | 561M | 635M | 737M | 737M |
| Total Assets | 643K | 329M | 686M | 793M | 1000M | 1.1B | 1.4B | 1.4B |
| Total Liabilities | N/A | 185M | 236M | 274M | 393M | 452M | 578M | 578M |
| Intangibles | N/A | 6.0M | 60M | 57M | 108M | 110M | 216M | 216M |
| Retained Earnings | N/A | -20M | -208M | -217M | -194M | -179M | -156M | -156M |
| Working Capital | -2.4M | 43M | 256M | 288M | 314M | 386M | 342M | 342M |
| Current Assets | 2.4M | 190M | 447M | 552M | 701M | 835M | 911M | 911M |
| Current Liabilities | 4.8M | 147M | 190M | 264M | 387M | 449M | 569M | 569M |
| Per Share Data | ||||||||
| EPS | 0.09 | 0.33 | -1.83 | -0.08 | 0.19 | 0.11 | 0.18 | 0.18 |
| Owner EPS | 0.25 | 0.39 | -1.95 | -0.23 | 0.31 | 0.35 | 0.65 | 0.65 |
| Book Value | N/A | 1.55 | 4.15 | 4.65 | 4.62 | 4.86 | 5.79 | 5.79 |
| Cash Flow/Share | 0.27 | 0.41 | 0.54 | 0.44 | 0.67 | 0.84 | 1.28 | 0.26 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 91.6M | 94.7M | 102.9M | 107.3M | 121.5M | 130.8M | 127.3M | 127.3M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | 126.0 | 180.5 | 134.1 | 127.8 |
| P/FCF | N/A | N/A | 49.6 | 52.2 | 36.0 | 23.8 | 18.8 | 17.9 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 71.8 |
| Price/Book | N/A | N/A | 6.3 | 4.9 | 5.2 | 4.1 | 4.2 | 4.0 |
| Price/Sales | N/A | N/A | 3.4 | 2.3 | 1.8 | 1.5 | 1.4 | 1.4 |
| FCF Yield | N/A | N/A | 2.0% | 1.9% | 2.8% | 4.2% | 5.3% | 5.6% |
| Market Cap | 0 | N/A | 2.7B | 2.5B | 2.9B | 2.6B | 3.1B | 2.9B |
| Avg. Price | 0.00 | N/A | 31.75 | 28.54 | 25.13 | 19.43 | 23.02 | 23.01 |
| Year-End Price | 0.00 | N/A | 26.30 | 22.90 | 23.94 | 19.85 | 24.13 | 23.01 |
Privia Health Group, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
Privia Health Group, Inc. trades at 127.8x trailing earnings, compared to its 15-year median P/E of 15.0x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 17.9x vs a median of 36.0x. At current prices, the estimated annualized return to fair value is +11.8%.
Privia Health Group, Inc. (PRVA) has a current P/E ratio of 127.8, compared to its historical median P/E of 15.0. The stock is currently considered Expensive based on its historical valuation range.
Privia Health Group, Inc. (PRVA) has a 5-year average return on invested capital (ROIC) of -10.0%. This is below average and may indicate limited pricing power.
Privia Health Group, Inc. (PRVA) has a market capitalization of $2.9B. It is classified as a mid-cap stock.
Privia Health Group, Inc. (PRVA) does not currently pay a regular dividend.
Based on historical P/E analysis, Privia Health Group, Inc. (PRVA) appears expensive. The current P/E of 127.8 is 752% above its historical median of 15.0. The estimated fair value CAGR (P/E method) is 3.2%.
Privia Health Group, Inc. (PRVA) operates in the Services-Health Services industry, within the Healthcare sector.
Privia Health Group, Inc. (PRVA) reported annual revenue of $2.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Privia Health Group, Inc. (PRVA) has a net profit margin of 1.1%. This is a modest margin.
Privia Health Group, Inc. (PRVA) generated $163 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Privia Health Group, Inc. (PRVA) has a debt-to-equity ratio of 0.01. This indicates a conservatively financed balance sheet.
Privia Health Group, Inc. (PRVA) reported earnings per share (EPS) of $0.18 in its most recent fiscal year.
Privia Health Group, Inc. (PRVA) has a return on equity (ROE) of 3.3%. This indicates moderate shareholder returns.
The Ledger Terminal provides 7 years of financial data for Privia Health Group, Inc. (PRVA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Privia Health Group, Inc. (PRVA) has a book value per share of $5.79, based on its most recent annual SEC filing.